Page 25 - atoday
P. 25

BUSINESS A25
                                                                                                                                                     Friday 26 February 2016

Tax group blasts Pfizer, urges stop to its tax-cutting deal 

LINDA A. JOHNSON                This photo shows the Pfizer logo on display at the company’s                    mention the deal’s impact         ly expired or will soon. It’s
AP Business Writer              world headquarters in New York. A consumer group is accusing                    on U.S. jobs. But it discuss-     standard procedure for
A consumer group is ac-         drugmaker Pfizer of seeking to avoid $35 billion in U.S. taxes with             es Pfizer’s impact on U.S.        Pfizer and most other drug-
cusing Pfizer of seeking to     its plan to buy fellow drugmaker Allergan in a deal structured to               patients and taxpayers in         makers to jack up the price
avoid $35 billion in U.S. tax-  nominally move Pfizer’s address to lower-tax Ireland, Allergan’s                depth.                            of their drugs at that point,
es with its plan to buy fel-    home.                                                                           It says that in recent years,     to make as much money
low drugmaker Allergan in                                                                                       Pfizer has repeatedly raised      as possible before cheaper
a deal structured to nomi-                                                            (AP Photo/Mark Lennihan)  prices of its top-selling drugs,  generic versions flood the
nally move Pfizer’s address                                                                                     including erectile dysfunc-       market and grab most of
to lower-tax Ireland, Aller-    er’s U.S. tax rate, on aver-  “The proposed combina-                            tion pill Viagra, pain treat-     the sales. The report notes
gan’s home.                     age, to 6.4 percent. That’s   tion of Pfizer and Allergan                       ments Lyrica and Celebrex         Pfizer benefits from an edu-
In a report released Thurs-     well below the 24 percent     will create a global, R&D-                        and antibiotic Zyvox. Pfizer      cated U.S. workforce and
day, Americans for Taxpay-      Pfizer has claimed.           focused company with the                          raised prices on those and        infrastructure here, and
er Fairness says that would     At a news conference in       ability to lead in the quest                      three other drugs by an av-       makes about 5 percent of
also slash future U.S. taxes    Washington, the group         to find cures and treat-                          erage of 39.2 percent from        its U.S. sales to the federal
paid by Pfizer Inc., which      and several members of        ments for patients with the                       2013 through 2015 — 23            government, about $1.01
will keep its operational       Congress said the fed-        most feared diseases and                          times overall inflation dur-      billion a year on average
headquarters at its New         eral government can and       conditions of our time, such                      ing that period — and this        from 2011 through 2014.
York City base. Pfizer would    should block Pfizer’s $160    as Alzheimer’s disease, Par-                      year raised prices on about       The report also states that
still have to pay U.S. taxes    billion acquisition of Al-    kinson’s disease, cancer                          60 drugs by more than 10          Pfizer gets tax credits av-
on income earned in the         lergan. Pfizer, the world’s   and rare genetic disorders.                       percent on average, ac-           eraging $118.1 million a
country, but not overseas.      second-biggest drugmaker      “This transaction is not                          cording to the report.            year by writing off part of its
The group has been urging       by revenue, says the deal     structured to move jobs out                       The tax group states that         costs for research and for
federal regulation changes      is set to be completed by     of the United States, where                       patients in Ireland pay           manufacturing done within
to block not just the Pfizer    December.                     we conduct the majority of                        about one-twelfth what            the U.S. It also claims Pfizer
deal, but a surge of other      In a statement to The As-     our research,” Pfizer wrote.                      Americans do for Pfizer’s         got tax breaks averag-
companies in various in-        sociated Press, Pfizer said,  The 28-page report doesn’t                        seven top drugs. That’s be-       ing $7 million a year from
dustries doing inversions                                                                                       cause Ireland and virtually       2011 through 2014 due to
to slash their U.S. tax bills.                                                                                  every country except the          a loophole that allows it to
That lost revenue ultimately                                                                                    U.S. sets limits on drug pric-    deduct excess compensa-
comes out of the pockets                                                                                        es, which are unregulated         tion given to top executives
of consumers and other                                                                                          here. The group suggests          in the form of stock options
taxpayers.                                                                                                      Pfizer should cut its drug        tied to their performance.
Americans for Taxpayer                                                                                          prices in the U.S. to what it     The report is the second
Fairness also accuses Pfizer                                                                                    charges in Ireland, which         one Americans for Tax-
of gouging Americans with                                                                                       isn’t likely to happen.           payer Fairness has issued
frequent and excessive                                                                                          Most of those seven drugs         since November criticizing
price hikes on its medicines                                                                                    have patents that recent-         Pfizer’s planned inversion.
while benefiting from mul-
tiple loopholes and tax de-
ductions that reduce Pfiz-

Japan’s Sharp accepts takeover, Foxconn balks 

YURI KAGEYAMA                   iPhones.                      country losing technology
AP Business Writer              Sharp chose Foxconn as its    to foreign interests.
TOKYO (AP) — Sharp Corp.        preferred partner in a two-   Media reports in Japan
announced Thursday it will      day board meeting end-        that a deal might be immi-
accept a 489 billion yen        ing Thursday, and said Fox-   nent had sent Sharp share
($4.4 billion) takeover by      conn would gain a 66 per-     prices initially higher on the
Taiwan’s Hon Hai Precision      cent stake in the company     Tokyo Stock Exchange, but
Industry Co., also known as     under the deal.               they finished 14 percent
Foxconn, but Foxconn said       Sharp spokeswoman Nali Li     lower after details of the
it was not ready to sign the    said the company had no       deal leaked. Sharp made
deal.                           official comment on the       the announcement after
“We will have to postpone       statement from Foxconn.       trading ended.
any signing of a definitive     It was unclear whether        Osaka-based Sharp has
agreement until we have         Foxconn was question-         long been a prized brand
arrived at a satisfactory un-   ing the content of Sharp’s    in Japan, beginning with its
derstanding and resolution      announcement, or just re-     sale of mechanical pencils,
of the situation,” Foxconn      questing more time to look    still known as “sharp pen-
Technology Group said in a      at details.                   cils” here. It also pioneered
statement.                      Sharp had been consider-      hand-held electronic de-
It did not elaborate. If the    ing both Foxconn’s bid and    vices.
deal goes through, Sharp        an offer from a Japanese      Sharp had its beginnings as
would become the first ma-      government-backed con-        a Tokyo-based metalwork-
jor Japanese electronics        sortium of Japanese inves-    ing shop in 1912. It later
maker to be acquired by a       tors.                         made its fame with Aquos
foreign company.                Despite Japan’s rapid glo-    flat-panel TVs and nifty
Foxconn is a major con-         balization, some have ex-     Internet-connecting cell-
tractor to Apple Inc., as-      pressed fears a Foxconn       phones, long before the ar-
sembling products such as       takeover will result in the   rival of iPhones in Japan.
   20   21   22   23   24   25   26   27   28   29   30